Received: 8 May 2018
Accepted: 10 July 2018
First Online: 28 July 2018
Ethics approval and consent to participate
: The study was approved by the Southampton and South West Hampshire Research Ethics Committee. All participants provided written informed consent.
: Not applicable.
: TMAW has received reimbursement for travel and meeting attendance from Boehringer Ingelheim and AstraZeneca, outside of the submitted work. SB received grants and assistance in travel to conferences from GSK outside of the submitted work. SCC received a grant from Pfizer outside of the submitted work. KJS received grants from Asthma UK (08/026) and BMA HC Roscoe Award outside of the submitted work, and he has a patent PCT/GB2010/050821 “Ex Vivo Modelling of Therapeutic Interventions” pending. EA, JMD and CL are employees of the GSK group of companies. EA and JMD hold shares/restricted shares in the GSK group of companies. KJS, VK, NPW, KO, SW, and TMAW received an institutional grant from the GSK group of companies to conduct this study. AW, NAC, SH and AT declare no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.